FA
IDXX icon

Faithward Advisors’s Idexx Laboratories IDXX Stock Holding History

Faithward Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Buy
+6,155
New +$3.45M 0.4% 73
2026
Q1 		– Sell
-5,910
Closed -$4M – 292
2025
Q4 		$4M Buy
5,910
+149
+3% +$101K 0.59% 48
2025
Q3 		$3.68M Buy
+5,761
New +$3.5M 0.55% 59
2022
Q3 		– Sell
-702
Closed -$246K – 256
2022
Q2 		$246K Sell
702
-223
-24% -$90.9K 0.06% 126
2022
Q1 		$506K Sell
925
-120
-11% -$63.1K 0.1% 97
2021
Q4 		$688K Sell
1,045
-1,121
-52% -$704K 0.13% 85
2021
Q3 		$1.35M Sell
2,166
-567
-21% -$381K 0.26% 59
2021
Q2 		$1.73M Sell
2,733
-5,741
-68% -$3.17M 0.34% 49
2021
Q1 		$4.15M Sell
8,474
-407
-5% -$204K 0.93% 25
2020
Q4 		$4.44M Sell
8,881
-1,856
-17% -$830K 1.94% 17
2020
Q3 		$4.22M Sell
10,737
-3,433
-24% -$1.27M 1.02% 31
2020
Q2 		$4.68M Buy
14,170
+2,699
+24% +$781K 1.21% 27
2020
Q1 		$2.78M Buy
11,471
+4,849
+73% +$1.27M 0.78% 35
2019
Q4 		$1.73M Buy
+6,622
New +$1.74M 0.41% 54

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Faithward Advisors's IDXX Position: Q2 2026 in Review

Faithward Advisors opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 6,155 shares worth $3.24M. The stake represents 0.4% of the portfolio and ranks #73 among its holdings. This is a return to the name: Faithward Advisors previously reported a position in IDXX as recently as Q4 2025.

Faithward Advisors first reported a position in IDXX in Q4 2019 and has held it in 14 quarters since. The position peaked at $4.68M in Q2 2020. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Faithward Advisors held 6,155 shares of Idexx Laboratories worth $3.24M as of Q2 2026.
  • Idexx Laboratories was a new Faithward Advisors position in Q2 2026.
  • Idexx Laboratories made up 0.4% of Faithward Advisors's portfolio in Q2 2026, its #73 holding.
  • Faithward Advisors first reported a position in Idexx Laboratories in Q4 2019 and has held it in 14 quarters since.
  • Faithward Advisors's Idexx Laboratories position peaked at $4.68M in Q2 2020.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.